PI Industries Ltd: Segment Analysis

PI Industries Ltd (PI Industries) is an integrated life sciences company. The company focuses on innovation-led solutions across agriculture and adjacent life science domains, spanning research, development, manufacturing, and distribution, with strong ESG and technology-led execution.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

PI Industries' R&D initiatives focused on its "science meets life" strategy, emphasizing agrochemical innovation, biologicals, green chemistry, and the development of pharma-linked capabilities. The company operated a robust, integrated R&D framework with two major centers and multiple supporting labs, facilitating a comprehensive pipeline from discovery to commercial manufacturing. The R&D organization comprised over 700 staff, including approximately 572 scientists and researchers, and 200+ PhDs. R&D efforts also focused on process sustainability, with innovations in biocatalysis, low-carbon product development, and solvent-free products. Advanced science and digital R&D were strengthened through computational tools and AI integration, while the biologicals R&D platform expanded through strategic acquisitions and alliances. In FY2025, the company filed 44 patents, with cumulative filings reaching 212. The company commercialized 13 new products and became the first Indian company to secure ISO approval for its proprietary insecticide active ingredient, PIOXANILIPROLE. In FY2025, the company incurred expenses of INR2,312 million on R&D, which as a percentage of revenue, stood at 2.9%.